Loading clinical trials...

Complex Aneurysm Registry - Real-World Evidence Data Collection Intracranial Aneurysm Treatment Devices | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATION

Complex Aneurysm Registry - Real-World Evidence Data Collection Intracranial Aneurysm Treatment Devices

NCT06215105•Microvention-Terumo, Inc.

View on ClinicalTrials.gov

Summary

To collect real-world evidence allowing assessment of functional, imaging, and safety outcomes of commercially available MicroVention devices used for the endovascular treatment of intracranial aneurysms (IA) at the direction of the treating physician.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Patient must have a single ruptured or unruptured IA for which endovascular treatment has been determined appropriate.
•2. Patient's IA will be treated using a commercially available MicroVention implant device as the primary treatment device and the decision to use this device has been made by the treating physician outside the context of the CAR study and prior to enrollment.
•Note: For the purposes of this protocol, ancillary/accessory devices such as balloon catheters and other access devices are not considered primary treatment devices.
•3. Patient or patient 's legally authorized representative (LAR) has provided written informed consent prior to treatment or no later than 48 hours post procedure for emergent treatment of a ruptured aneurysm.
•4. Patient must be considered by the treating physician to be available for and able to complete study follow-up visits.

Exclusion Criteria

•1. Target aneurysm has been previously treated via surgical or endovascular means.
•2. Patient is enrolled in another device or drug study in which participation could confound study results.
•3. Patient has a life expectancy of less than 1 year due to other illness or condition (in addition to an intracranial aneurysm).
•4. Patient has been previously enrolled into this study.

Locations (5)

Memorial Healthcare System

Hollywood, Florida, United States

Orlando Health

Orlando, Florida, United States

University of Iowa

Iowa City, Iowa, United States

Abbott Northwestern Hospital

Minneapolis, Minnesota, United States

Albany Medical Center

Albany, New York, United States

Key Dates

Start Date

January 8, 2024

Primary Completion Date

January 8, 2029

Completion Date

January 8, 2029

Last Updated

October 1, 2025

Enrollment

750

ESTIMATED participants

Conditions

Aneurysm Cerebral

Interventions

Intracranial Aneurysm Devices

DEVICE

Kaneka Endovascular Embolization and Protection

NCT05563051

Aneurysm Cerebral

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 1, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions